SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-003213
Filing Date
2018-02-23
Accepted
2018-02-23 14:26:19
Documents
16
Period of Report
2018-02-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20180221_8k.htm 8-K 30116
2 EXHIBIT 99.1 ex_105649.htm EX-99.1 35710
3 EXHIBIT 99.2 ex_105650.htm EX-99.2 6632
4 slide11.jpg GRAPHIC 94463
5 slide10.jpg GRAPHIC 181960
6 slide09.jpg GRAPHIC 306549
7 slide08.jpg GRAPHIC 186994
8 slide07.jpg GRAPHIC 301452
9 slide06.jpg GRAPHIC 254322
10 slide05.jpg GRAPHIC 300249
11 slide04.jpg GRAPHIC 249097
12 slide03.jpg GRAPHIC 107340
13 slide02.jpg GRAPHIC 404304
14 slide01.jpg GRAPHIC 94463
15 ex99-1img002.jpg GRAPHIC 3740
16 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-18-003213.txt   3488763
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 18635889
SIC: 2834 Pharmaceutical Preparations